nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—type 2 diabetes mellitus—coronary artery disease	0.389	1	CtDrD
Rosiglitazone—PPARG—coronary artery disease	0.0838	0.487	CbGaD
Rosiglitazone—CYP2C19—coronary artery disease	0.0569	0.33	CbGaD
Rosiglitazone—PPARG—Telmisartan—coronary artery disease	0.032	0.105	CbGbCtD
Rosiglitazone—ALB—coronary artery disease	0.0315	0.183	CbGaD
Rosiglitazone—SLCO1B1—Gemfibrozil—coronary artery disease	0.0145	0.0475	CbGbCtD
Rosiglitazone—SLCO1B1—Olmesartan—coronary artery disease	0.0137	0.045	CbGbCtD
Rosiglitazone—SLCO1B1—Pitavastatin—coronary artery disease	0.011	0.036	CbGbCtD
Rosiglitazone—SLCO1B1—Valsartan—coronary artery disease	0.0107	0.035	CbGbCtD
Rosiglitazone—SLCO1B1—Ezetimibe—coronary artery disease	0.0081	0.0265	CbGbCtD
Rosiglitazone—SLCO1B1—Rosuvastatin—coronary artery disease	0.0081	0.0265	CbGbCtD
Rosiglitazone—CYP2C8—Fenofibrate—coronary artery disease	0.00767	0.0251	CbGbCtD
Rosiglitazone—SLCO1B1—Simvastatin—coronary artery disease	0.00753	0.0247	CbGbCtD
Rosiglitazone—SLCO1B1—Pravastatin—coronary artery disease	0.00737	0.0241	CbGbCtD
Rosiglitazone—SLCO1B1—Lovastatin—coronary artery disease	0.00737	0.0241	CbGbCtD
Rosiglitazone—SLCO1B1—Atorvastatin—coronary artery disease	0.00671	0.022	CbGbCtD
Rosiglitazone—SLCO1B1—Losartan—coronary artery disease	0.00614	0.0201	CbGbCtD
Rosiglitazone—CYP2C8—Gemfibrozil—coronary artery disease	0.00613	0.0201	CbGbCtD
Rosiglitazone—ALB—Pitavastatin—coronary artery disease	0.00602	0.0197	CbGbCtD
Rosiglitazone—ALB—Valsartan—coronary artery disease	0.00585	0.0192	CbGbCtD
Rosiglitazone—PTGS1—Acetylsalicylic acid—coronary artery disease	0.00579	0.019	CbGbCtD
Rosiglitazone—CYP2C9—Fenofibrate—coronary artery disease	0.00535	0.0175	CbGbCtD
Rosiglitazone—CYP2C8—Clopidogrel—coronary artery disease	0.00532	0.0174	CbGbCtD
Rosiglitazone—CYP2C19—Gemfibrozil—coronary artery disease	0.00515	0.0169	CbGbCtD
Rosiglitazone—CYP1A2—Gemfibrozil—coronary artery disease	0.00475	0.0155	CbGbCtD
Rosiglitazone—CYP2C8—Pitavastatin—coronary artery disease	0.00465	0.0152	CbGbCtD
Rosiglitazone—CYP2C19—Clopidogrel—coronary artery disease	0.00446	0.0146	CbGbCtD
Rosiglitazone—ALB—Rosuvastatin—coronary artery disease	0.00443	0.0145	CbGbCtD
Rosiglitazone—ALB—Acetylsalicylic acid—coronary artery disease	0.00432	0.0142	CbGbCtD
Rosiglitazone—CYP2C9—Gemfibrozil—coronary artery disease	0.00428	0.014	CbGbCtD
Rosiglitazone—ALB—Captopril—coronary artery disease	0.00427	0.014	CbGbCtD
Rosiglitazone—CYP1A2—Clopidogrel—coronary artery disease	0.00412	0.0135	CbGbCtD
Rosiglitazone—CYP2C19—Telmisartan—coronary artery disease	0.0039	0.0128	CbGbCtD
Rosiglitazone—CYP2C9—Clopidogrel—coronary artery disease	0.00371	0.0121	CbGbCtD
Rosiglitazone—ALB—Furosemide—coronary artery disease	0.00343	0.0112	CbGbCtD
Rosiglitazone—ALB—Losartan—coronary artery disease	0.00336	0.011	CbGbCtD
Rosiglitazone—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00334	0.0109	CbGbCtD
Rosiglitazone—CYP2C9—Pitavastatin—coronary artery disease	0.00324	0.0106	CbGbCtD
Rosiglitazone—CYP2C8—Simvastatin—coronary artery disease	0.00319	0.0104	CbGbCtD
Rosiglitazone—CYP2C9—Valsartan—coronary artery disease	0.00315	0.0103	CbGbCtD
Rosiglitazone—CYP2C19—Timolol—coronary artery disease	0.00314	0.0103	CbGbCtD
Rosiglitazone—CYP2C8—Lovastatin—coronary artery disease	0.00312	0.0102	CbGbCtD
Rosiglitazone—CYP2C8—Pravastatin—coronary artery disease	0.00312	0.0102	CbGbCtD
Rosiglitazone—CYP2C19—Rosuvastatin—coronary artery disease	0.00288	0.00941	CbGbCtD
Rosiglitazone—CYP2C8—Atorvastatin—coronary artery disease	0.00284	0.0093	CbGbCtD
Rosiglitazone—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.0028	0.00918	CbGbCtD
Rosiglitazone—CYP2C9—cardial valve—coronary artery disease	0.00267	0.237	CbGeAlD
Rosiglitazone—CYP2C19—Simvastatin—coronary artery disease	0.00267	0.00875	CbGbCtD
Rosiglitazone—CYP2C19—Lovastatin—coronary artery disease	0.00262	0.00857	CbGbCtD
Rosiglitazone—CYP2C8—Losartan—coronary artery disease	0.0026	0.00851	CbGbCtD
Rosiglitazone—CYP2D6—Niacin—coronary artery disease	0.00257	0.00842	CbGbCtD
Rosiglitazone—CYP2C9—Rosuvastatin—coronary artery disease	0.00239	0.00783	CbGbCtD
Rosiglitazone—CYP2D6—Timolol—coronary artery disease	0.00239	0.00783	CbGbCtD
Rosiglitazone—CYP2C19—Atorvastatin—coronary artery disease	0.00238	0.0078	CbGbCtD
Rosiglitazone—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00233	0.00763	CbGbCtD
Rosiglitazone—CYP2C9—Simvastatin—coronary artery disease	0.00222	0.00728	CbGbCtD
Rosiglitazone—CYP2C19—Losartan—coronary artery disease	0.00218	0.00714	CbGbCtD
Rosiglitazone—CYP2C9—Pravastatin—coronary artery disease	0.00217	0.00712	CbGbCtD
Rosiglitazone—CYP2C9—Lovastatin—coronary artery disease	0.00217	0.00712	CbGbCtD
Rosiglitazone—CYP2D6—Captopril—coronary artery disease	0.0021	0.00689	CbGbCtD
Rosiglitazone—CYP2D6—Simvastatin—coronary artery disease	0.00203	0.00665	CbGbCtD
Rosiglitazone—CYP1A2—Losartan—coronary artery disease	0.00201	0.00658	CbGbCtD
Rosiglitazone—CYP2D6—Lovastatin—coronary artery disease	0.00199	0.00651	CbGbCtD
Rosiglitazone—CYP2D6—Pravastatin—coronary artery disease	0.00199	0.00651	CbGbCtD
Rosiglitazone—CYP2C9—Atorvastatin—coronary artery disease	0.00198	0.00649	CbGbCtD
Rosiglitazone—CYP2C9—Losartan—coronary artery disease	0.00181	0.00593	CbGbCtD
Rosiglitazone—CYP2D6—Atorvastatin—coronary artery disease	0.00181	0.00593	CbGbCtD
Rosiglitazone—ACSL4—cardiac ventricle—coronary artery disease	0.000854	0.0757	CbGeAlD
Rosiglitazone—ACSL4—myocardium—coronary artery disease	0.000804	0.0712	CbGeAlD
Rosiglitazone—PPARG—artery—coronary artery disease	0.000685	0.0607	CbGeAlD
Rosiglitazone—PPARG—endothelium—coronary artery disease	0.000579	0.0513	CbGeAlD
Rosiglitazone—ACSL4—heart—coronary artery disease	0.000561	0.0497	CbGeAlD
Rosiglitazone—ACSL4—cardiovascular system—coronary artery disease	0.000529	0.0469	CbGeAlD
Rosiglitazone—Pioglitazone—PPARG—coronary artery disease	0.000497	0.596	CrCbGaD
Rosiglitazone—ACSL4—cardiac atrium—coronary artery disease	0.00048	0.0425	CbGeAlD
Rosiglitazone—ACSL4—blood—coronary artery disease	0.000419	0.0371	CbGeAlD
Rosiglitazone—PTGS1—artery—coronary artery disease	0.000366	0.0324	CbGeAlD
Rosiglitazone—PPARG—myocardium—coronary artery disease	0.000362	0.032	CbGeAlD
Rosiglitazone—Pioglitazone—CYP2C19—coronary artery disease	0.000337	0.404	CrCbGaD
Rosiglitazone—PTGS1—endothelium—coronary artery disease	0.000309	0.0274	CbGeAlD
Rosiglitazone—PPARG—heart—coronary artery disease	0.000252	0.0224	CbGeAlD
Rosiglitazone—PPARG—cardiovascular system—coronary artery disease	0.000238	0.0211	CbGeAlD
Rosiglitazone—ALB—heart—coronary artery disease	0.000237	0.021	CbGeAlD
Rosiglitazone—SLCO1B1—blood—coronary artery disease	0.000218	0.0193	CbGeAlD
Rosiglitazone—PTGS1—myocardium—coronary artery disease	0.000193	0.0171	CbGeAlD
Rosiglitazone—PPARG—blood—coronary artery disease	0.000188	0.0167	CbGeAlD
Rosiglitazone—CYP2C9—heart—coronary artery disease	0.000148	0.0131	CbGeAlD
Rosiglitazone—CYP2C19—blood—coronary artery disease	0.000142	0.0126	CbGeAlD
Rosiglitazone—CYP2C9—cardiovascular system—coronary artery disease	0.000139	0.0124	CbGeAlD
Rosiglitazone—PTGS1—heart—coronary artery disease	0.000135	0.012	CbGeAlD
Rosiglitazone—PTGS1—cardiovascular system—coronary artery disease	0.000127	0.0113	CbGeAlD
Rosiglitazone—CYP2C8—blood—coronary artery disease	0.000124	0.011	CbGeAlD
Rosiglitazone—CYP1A2—blood—coronary artery disease	0.000116	0.0103	CbGeAlD
Rosiglitazone—PTGS1—cardiac atrium—coronary artery disease	0.000115	0.0102	CbGeAlD
Rosiglitazone—CYP2C9—blood—coronary artery disease	0.00011	0.00977	CbGeAlD
Rosiglitazone—PTGS1—blood—coronary artery disease	0.000101	0.00892	CbGeAlD
Rosiglitazone—CYP2D6—blood—coronary artery disease	8.28e-05	0.00733	CbGeAlD
Rosiglitazone—Anaphylactic shock—Furosemide—coronary artery disease	5.58e-05	0.000775	CcSEcCtD
Rosiglitazone—Erythema multiforme—Lisinopril—coronary artery disease	5.58e-05	0.000774	CcSEcCtD
Rosiglitazone—Headache—Rosuvastatin—coronary artery disease	5.58e-05	0.000773	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Telmisartan—coronary artery disease	5.54e-05	0.000769	CcSEcCtD
Rosiglitazone—Asthenia—Fenofibrate—coronary artery disease	5.54e-05	0.000769	CcSEcCtD
Rosiglitazone—Malnutrition—Timolol—coronary artery disease	5.53e-05	0.000768	CcSEcCtD
Rosiglitazone—Fatigue—Pravastatin—coronary artery disease	5.5e-05	0.000763	CcSEcCtD
Rosiglitazone—Nervous system disorder—Furosemide—coronary artery disease	5.48e-05	0.00076	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Furosemide—coronary artery disease	5.47e-05	0.000759	CcSEcCtD
Rosiglitazone—Pruritus—Fenofibrate—coronary artery disease	5.46e-05	0.000758	CcSEcCtD
Rosiglitazone—Constipation—Pravastatin—coronary artery disease	5.45e-05	0.000757	CcSEcCtD
Rosiglitazone—Rash—Acetylsalicylic acid—coronary artery disease	5.45e-05	0.000756	CcSEcCtD
Rosiglitazone—Asthenia—Clopidogrel—coronary artery disease	5.45e-05	0.000756	CcSEcCtD
Rosiglitazone—Dermatitis—Acetylsalicylic acid—coronary artery disease	5.45e-05	0.000756	CcSEcCtD
Rosiglitazone—Asthenia—Lovastatin—coronary artery disease	5.41e-05	0.000751	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Captopril—coronary artery disease	5.39e-05	0.000748	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Losartan—coronary artery disease	5.39e-05	0.000748	CcSEcCtD
Rosiglitazone—Oedema—Losartan—coronary artery disease	5.39e-05	0.000748	CcSEcCtD
Rosiglitazone—Pruritus—Clopidogrel—coronary artery disease	5.37e-05	0.000745	CcSEcCtD
Rosiglitazone—Infection—Losartan—coronary artery disease	5.35e-05	0.000743	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Trandolapril—coronary artery disease	5.35e-05	0.000742	CcSEcCtD
Rosiglitazone—Fatigue—Trandolapril—coronary artery disease	5.34e-05	0.000741	CcSEcCtD
Rosiglitazone—Pruritus—Lovastatin—coronary artery disease	5.34e-05	0.00074	CcSEcCtD
Rosiglitazone—Fatigue—Enalapril—coronary artery disease	5.32e-05	0.000738	CcSEcCtD
Rosiglitazone—Asthenia—Ezetimibe—coronary artery disease	5.31e-05	0.000736	CcSEcCtD
Rosiglitazone—Constipation—Trandolapril—coronary artery disease	5.3e-05	0.000735	CcSEcCtD
Rosiglitazone—Urticaria—Valsartan—coronary artery disease	5.29e-05	0.000734	CcSEcCtD
Rosiglitazone—Nausea—Rosuvastatin—coronary artery disease	5.29e-05	0.000733	CcSEcCtD
Rosiglitazone—Diarrhoea—Fenofibrate—coronary artery disease	5.28e-05	0.000733	CcSEcCtD
Rosiglitazone—Nervous system disorder—Losartan—coronary artery disease	5.28e-05	0.000733	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Losartan—coronary artery disease	5.28e-05	0.000732	CcSEcCtD
Rosiglitazone—Constipation—Enalapril—coronary artery disease	5.28e-05	0.000732	CcSEcCtD
Rosiglitazone—Urticaria—Olmesartan—coronary artery disease	5.27e-05	0.000731	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Telmisartan—coronary artery disease	5.25e-05	0.000729	CcSEcCtD
Rosiglitazone—Fatigue—Telmisartan—coronary artery disease	5.25e-05	0.000728	CcSEcCtD
Rosiglitazone—Pruritus—Ezetimibe—coronary artery disease	5.23e-05	0.000726	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Perindopril—coronary artery disease	5.23e-05	0.000726	CcSEcCtD
Rosiglitazone—Constipation—Telmisartan—coronary artery disease	5.2e-05	0.000722	CcSEcCtD
Rosiglitazone—Diarrhoea—Clopidogrel—coronary artery disease	5.19e-05	0.000721	CcSEcCtD
Rosiglitazone—Asthenia—Eplerenone—coronary artery disease	5.19e-05	0.000721	CcSEcCtD
Rosiglitazone—Angioedema—Ramipril—coronary artery disease	5.17e-05	0.000718	CcSEcCtD
Rosiglitazone—Diarrhoea—Lovastatin—coronary artery disease	5.16e-05	0.000716	CcSEcCtD
Rosiglitazone—Urticaria—Niacin—coronary artery disease	5.15e-05	0.000714	CcSEcCtD
Rosiglitazone—Nausea—Acetylsalicylic acid—coronary artery disease	5.14e-05	0.000712	CcSEcCtD
Rosiglitazone—Malnutrition—Lisinopril—coronary artery disease	5.13e-05	0.000712	CcSEcCtD
Rosiglitazone—Pruritus—Eplerenone—coronary artery disease	5.12e-05	0.000711	CcSEcCtD
Rosiglitazone—Dizziness—Fenofibrate—coronary artery disease	5.11e-05	0.000709	CcSEcCtD
Rosiglitazone—Fatigue—Captopril—coronary artery disease	5.1e-05	0.000708	CcSEcCtD
Rosiglitazone—Leukopenia—Ramipril—coronary artery disease	5.07e-05	0.000703	CcSEcCtD
Rosiglitazone—Urticaria—Pravastatin—coronary artery disease	5.07e-05	0.000703	CcSEcCtD
Rosiglitazone—Asthenia—Simvastatin—coronary artery disease	5.06e-05	0.000702	CcSEcCtD
Rosiglitazone—Diarrhoea—Ezetimibe—coronary artery disease	5.06e-05	0.000702	CcSEcCtD
Rosiglitazone—Constipation—Captopril—coronary artery disease	5.06e-05	0.000702	CcSEcCtD
Rosiglitazone—Angioedema—Timolol—coronary artery disease	5.06e-05	0.000702	CcSEcCtD
Rosiglitazone—Dizziness—Clopidogrel—coronary artery disease	5.02e-05	0.000697	CcSEcCtD
Rosiglitazone—Pruritus—Simvastatin—coronary artery disease	4.99e-05	0.000692	CcSEcCtD
Rosiglitazone—Dizziness—Lovastatin—coronary artery disease	4.99e-05	0.000692	CcSEcCtD
Rosiglitazone—Back pain—Lisinopril—coronary artery disease	4.97e-05	0.000689	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Perindopril—coronary artery disease	4.96e-05	0.000688	CcSEcCtD
Rosiglitazone—Diarrhoea—Eplerenone—coronary artery disease	4.95e-05	0.000687	CcSEcCtD
Rosiglitazone—Fatigue—Perindopril—coronary artery disease	4.95e-05	0.000687	CcSEcCtD
Rosiglitazone—Urticaria—Trandolapril—coronary artery disease	4.92e-05	0.000683	CcSEcCtD
Rosiglitazone—Constipation—Perindopril—coronary artery disease	4.91e-05	0.000682	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Losartan—coronary artery disease	4.91e-05	0.000681	CcSEcCtD
Rosiglitazone—Urticaria—Enalapril—coronary artery disease	4.9e-05	0.00068	CcSEcCtD
Rosiglitazone—Dizziness—Ezetimibe—coronary artery disease	4.89e-05	0.000679	CcSEcCtD
Rosiglitazone—Rash—Fenofibrate—coronary artery disease	4.87e-05	0.000676	CcSEcCtD
Rosiglitazone—Dermatitis—Fenofibrate—coronary artery disease	4.87e-05	0.000675	CcSEcCtD
Rosiglitazone—Headache—Fenofibrate—coronary artery disease	4.84e-05	0.000671	CcSEcCtD
Rosiglitazone—Urticaria—Telmisartan—coronary artery disease	4.83e-05	0.000671	CcSEcCtD
Rosiglitazone—Diarrhoea—Simvastatin—coronary artery disease	4.83e-05	0.00067	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Furosemide—coronary artery disease	4.82e-05	0.000669	CcSEcCtD
Rosiglitazone—Arthralgia—Ramipril—coronary artery disease	4.82e-05	0.000669	CcSEcCtD
Rosiglitazone—Myalgia—Ramipril—coronary artery disease	4.82e-05	0.000669	CcSEcCtD
Rosiglitazone—Fatigue—Furosemide—coronary artery disease	4.81e-05	0.000668	CcSEcCtD
Rosiglitazone—Dizziness—Eplerenone—coronary artery disease	4.79e-05	0.000664	CcSEcCtD
Rosiglitazone—Rash—Clopidogrel—coronary artery disease	4.79e-05	0.000664	CcSEcCtD
Rosiglitazone—Dermatitis—Clopidogrel—coronary artery disease	4.78e-05	0.000664	CcSEcCtD
Rosiglitazone—Asthenia—Valsartan—coronary artery disease	4.78e-05	0.000663	CcSEcCtD
Rosiglitazone—Hypertension—Timolol—coronary artery disease	4.78e-05	0.000663	CcSEcCtD
Rosiglitazone—Constipation—Furosemide—coronary artery disease	4.78e-05	0.000663	CcSEcCtD
Rosiglitazone—Asthenia—Olmesartan—coronary artery disease	4.76e-05	0.00066	CcSEcCtD
Rosiglitazone—Headache—Clopidogrel—coronary artery disease	4.76e-05	0.00066	CcSEcCtD
Rosiglitazone—Rash—Lovastatin—coronary artery disease	4.76e-05	0.00066	CcSEcCtD
Rosiglitazone—Dermatitis—Lovastatin—coronary artery disease	4.75e-05	0.000659	CcSEcCtD
Rosiglitazone—Anaemia—Lisinopril—coronary artery disease	4.75e-05	0.000658	CcSEcCtD
Rosiglitazone—Headache—Lovastatin—coronary artery disease	4.72e-05	0.000656	CcSEcCtD
Rosiglitazone—Pruritus—Valsartan—coronary artery disease	4.71e-05	0.000654	CcSEcCtD
Rosiglitazone—Arthralgia—Timolol—coronary artery disease	4.71e-05	0.000654	CcSEcCtD
Rosiglitazone—Myalgia—Timolol—coronary artery disease	4.71e-05	0.000654	CcSEcCtD
Rosiglitazone—Angioedema—Lisinopril—coronary artery disease	4.69e-05	0.000651	CcSEcCtD
Rosiglitazone—Pruritus—Olmesartan—coronary artery disease	4.69e-05	0.000651	CcSEcCtD
Rosiglitazone—Dizziness—Simvastatin—coronary artery disease	4.67e-05	0.000647	CcSEcCtD
Rosiglitazone—Rash—Ezetimibe—coronary artery disease	4.66e-05	0.000647	CcSEcCtD
Rosiglitazone—Dermatitis—Ezetimibe—coronary artery disease	4.66e-05	0.000646	CcSEcCtD
Rosiglitazone—Asthenia—Niacin—coronary artery disease	4.65e-05	0.000645	CcSEcCtD
Rosiglitazone—Fatigue—Losartan—coronary artery disease	4.65e-05	0.000644	CcSEcCtD
Rosiglitazone—Headache—Ezetimibe—coronary artery disease	4.63e-05	0.000643	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Ramipril—coronary artery disease	4.62e-05	0.000641	CcSEcCtD
Rosiglitazone—Oedema—Ramipril—coronary artery disease	4.62e-05	0.000641	CcSEcCtD
Rosiglitazone—Constipation—Losartan—coronary artery disease	4.61e-05	0.000639	CcSEcCtD
Rosiglitazone—Leukopenia—Lisinopril—coronary artery disease	4.6e-05	0.000638	CcSEcCtD
Rosiglitazone—Nausea—Fenofibrate—coronary artery disease	4.59e-05	0.000637	CcSEcCtD
Rosiglitazone—Pruritus—Niacin—coronary artery disease	4.58e-05	0.000636	CcSEcCtD
Rosiglitazone—Asthenia—Pravastatin—coronary artery disease	4.58e-05	0.000635	CcSEcCtD
Rosiglitazone—Rash—Eplerenone—coronary artery disease	4.57e-05	0.000633	CcSEcCtD
Rosiglitazone—Urticaria—Perindopril—coronary artery disease	4.56e-05	0.000633	CcSEcCtD
Rosiglitazone—Dermatitis—Eplerenone—coronary artery disease	4.56e-05	0.000633	CcSEcCtD
Rosiglitazone—Diarrhoea—Valsartan—coronary artery disease	4.56e-05	0.000632	CcSEcCtD
Rosiglitazone—Diarrhoea—Olmesartan—coronary artery disease	4.54e-05	0.000629	CcSEcCtD
Rosiglitazone—Headache—Eplerenone—coronary artery disease	4.54e-05	0.000629	CcSEcCtD
Rosiglitazone—Nervous system disorder—Ramipril—coronary artery disease	4.53e-05	0.000629	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Ramipril—coronary artery disease	4.52e-05	0.000628	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Timolol—coronary artery disease	4.52e-05	0.000627	CcSEcCtD
Rosiglitazone—Oedema—Timolol—coronary artery disease	4.52e-05	0.000627	CcSEcCtD
Rosiglitazone—Pruritus—Pravastatin—coronary artery disease	4.51e-05	0.000626	CcSEcCtD
Rosiglitazone—Nausea—Clopidogrel—coronary artery disease	4.51e-05	0.000626	CcSEcCtD
Rosiglitazone—Infection—Timolol—coronary artery disease	4.49e-05	0.000623	CcSEcCtD
Rosiglitazone—Nausea—Lovastatin—coronary artery disease	4.48e-05	0.000622	CcSEcCtD
Rosiglitazone—Rash—Simvastatin—coronary artery disease	4.45e-05	0.000617	CcSEcCtD
Rosiglitazone—Dermatitis—Simvastatin—coronary artery disease	4.44e-05	0.000617	CcSEcCtD
Rosiglitazone—Asthenia—Trandolapril—coronary artery disease	4.44e-05	0.000617	CcSEcCtD
Rosiglitazone—Urticaria—Furosemide—coronary artery disease	4.44e-05	0.000615	CcSEcCtD
Rosiglitazone—Diarrhoea—Niacin—coronary artery disease	4.43e-05	0.000615	CcSEcCtD
Rosiglitazone—Nervous system disorder—Timolol—coronary artery disease	4.43e-05	0.000615	CcSEcCtD
Rosiglitazone—Asthenia—Enalapril—coronary artery disease	4.43e-05	0.000614	CcSEcCtD
Rosiglitazone—Headache—Simvastatin—coronary artery disease	4.42e-05	0.000613	CcSEcCtD
Rosiglitazone—Dizziness—Valsartan—coronary artery disease	4.41e-05	0.000611	CcSEcCtD
Rosiglitazone—Nausea—Ezetimibe—coronary artery disease	4.39e-05	0.00061	CcSEcCtD
Rosiglitazone—Dizziness—Olmesartan—coronary artery disease	4.38e-05	0.000608	CcSEcCtD
Rosiglitazone—Pruritus—Trandolapril—coronary artery disease	4.38e-05	0.000608	CcSEcCtD
Rosiglitazone—Myalgia—Lisinopril—coronary artery disease	4.37e-05	0.000606	CcSEcCtD
Rosiglitazone—Arthralgia—Lisinopril—coronary artery disease	4.37e-05	0.000606	CcSEcCtD
Rosiglitazone—Asthenia—Telmisartan—coronary artery disease	4.37e-05	0.000606	CcSEcCtD
Rosiglitazone—Pruritus—Enalapril—coronary artery disease	4.36e-05	0.000605	CcSEcCtD
Rosiglitazone—Diarrhoea—Pravastatin—coronary artery disease	4.36e-05	0.000605	CcSEcCtD
Rosiglitazone—Pruritus—Telmisartan—coronary artery disease	4.3e-05	0.000597	CcSEcCtD
Rosiglitazone—Nausea—Eplerenone—coronary artery disease	4.3e-05	0.000597	CcSEcCtD
Rosiglitazone—Dizziness—Niacin—coronary artery disease	4.28e-05	0.000594	CcSEcCtD
Rosiglitazone—Urticaria—Losartan—coronary artery disease	4.28e-05	0.000594	CcSEcCtD
Rosiglitazone—Asthenia—Captopril—coronary artery disease	4.24e-05	0.000589	CcSEcCtD
Rosiglitazone—Diarrhoea—Trandolapril—coronary artery disease	4.24e-05	0.000588	CcSEcCtD
Rosiglitazone—Diarrhoea—Enalapril—coronary artery disease	4.22e-05	0.000586	CcSEcCtD
Rosiglitazone—Dizziness—Pravastatin—coronary artery disease	4.22e-05	0.000585	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Ramipril—coronary artery disease	4.21e-05	0.000584	CcSEcCtD
Rosiglitazone—Rash—Valsartan—coronary artery disease	4.2e-05	0.000583	CcSEcCtD
Rosiglitazone—Dermatitis—Valsartan—coronary artery disease	4.2e-05	0.000582	CcSEcCtD
Rosiglitazone—Nausea—Simvastatin—coronary artery disease	4.19e-05	0.000581	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Lisinopril—coronary artery disease	4.19e-05	0.000581	CcSEcCtD
Rosiglitazone—Oedema—Lisinopril—coronary artery disease	4.19e-05	0.000581	CcSEcCtD
Rosiglitazone—Pruritus—Captopril—coronary artery disease	4.19e-05	0.000581	CcSEcCtD
Rosiglitazone—Rash—Olmesartan—coronary artery disease	4.18e-05	0.00058	CcSEcCtD
Rosiglitazone—Dermatitis—Olmesartan—coronary artery disease	4.18e-05	0.000579	CcSEcCtD
Rosiglitazone—Headache—Valsartan—coronary artery disease	4.17e-05	0.000579	CcSEcCtD
Rosiglitazone—Diarrhoea—Telmisartan—coronary artery disease	4.16e-05	0.000578	CcSEcCtD
Rosiglitazone—Infection—Lisinopril—coronary artery disease	4.16e-05	0.000578	CcSEcCtD
Rosiglitazone—Headache—Olmesartan—coronary artery disease	4.15e-05	0.000576	CcSEcCtD
Rosiglitazone—Asthenia—Perindopril—coronary artery disease	4.12e-05	0.000572	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Timolol—coronary artery disease	4.11e-05	0.000571	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Lisinopril—coronary artery disease	4.1e-05	0.000569	CcSEcCtD
Rosiglitazone—Dizziness—Trandolapril—coronary artery disease	4.1e-05	0.000568	CcSEcCtD
Rosiglitazone—Rash—Niacin—coronary artery disease	4.08e-05	0.000567	CcSEcCtD
Rosiglitazone—Dermatitis—Niacin—coronary artery disease	4.08e-05	0.000566	CcSEcCtD
Rosiglitazone—Dizziness—Enalapril—coronary artery disease	4.08e-05	0.000566	CcSEcCtD
Rosiglitazone—Pruritus—Perindopril—coronary artery disease	4.06e-05	0.000564	CcSEcCtD
Rosiglitazone—Headache—Niacin—coronary artery disease	4.06e-05	0.000563	CcSEcCtD
Rosiglitazone—Diarrhoea—Captopril—coronary artery disease	4.05e-05	0.000562	CcSEcCtD
Rosiglitazone—Dizziness—Telmisartan—coronary artery disease	4.02e-05	0.000558	CcSEcCtD
Rosiglitazone—Rash—Pravastatin—coronary artery disease	4.02e-05	0.000558	CcSEcCtD
Rosiglitazone—Dermatitis—Pravastatin—coronary artery disease	4.02e-05	0.000557	CcSEcCtD
Rosiglitazone—Asthenia—Furosemide—coronary artery disease	4.01e-05	0.000556	CcSEcCtD
Rosiglitazone—Headache—Pravastatin—coronary artery disease	4e-05	0.000554	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Ramipril—coronary artery disease	3.99e-05	0.000553	CcSEcCtD
Rosiglitazone—Fatigue—Ramipril—coronary artery disease	3.98e-05	0.000553	CcSEcCtD
Rosiglitazone—Nausea—Valsartan—coronary artery disease	3.96e-05	0.000549	CcSEcCtD
Rosiglitazone—Pruritus—Furosemide—coronary artery disease	3.95e-05	0.000548	CcSEcCtD
Rosiglitazone—Constipation—Ramipril—coronary artery disease	3.95e-05	0.000548	CcSEcCtD
Rosiglitazone—Nausea—Olmesartan—coronary artery disease	3.94e-05	0.000546	CcSEcCtD
Rosiglitazone—Diarrhoea—Perindopril—coronary artery disease	3.93e-05	0.000545	CcSEcCtD
Rosiglitazone—Dizziness—Captopril—coronary artery disease	3.91e-05	0.000543	CcSEcCtD
Rosiglitazone—Rash—Trandolapril—coronary artery disease	3.91e-05	0.000542	CcSEcCtD
Rosiglitazone—Dermatitis—Trandolapril—coronary artery disease	3.9e-05	0.000541	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Timolol—coronary artery disease	3.9e-05	0.000541	CcSEcCtD
Rosiglitazone—Fatigue—Timolol—coronary artery disease	3.89e-05	0.00054	CcSEcCtD
Rosiglitazone—Rash—Enalapril—coronary artery disease	3.89e-05	0.00054	CcSEcCtD
Rosiglitazone—Dermatitis—Enalapril—coronary artery disease	3.89e-05	0.000539	CcSEcCtD
Rosiglitazone—Headache—Trandolapril—coronary artery disease	3.88e-05	0.000538	CcSEcCtD
Rosiglitazone—Asthenia—Losartan—coronary artery disease	3.87e-05	0.000536	CcSEcCtD
Rosiglitazone—Headache—Enalapril—coronary artery disease	3.86e-05	0.000536	CcSEcCtD
Rosiglitazone—Nausea—Niacin—coronary artery disease	3.85e-05	0.000534	CcSEcCtD
Rosiglitazone—Rash—Telmisartan—coronary artery disease	3.84e-05	0.000532	CcSEcCtD
Rosiglitazone—Dermatitis—Telmisartan—coronary artery disease	3.83e-05	0.000532	CcSEcCtD
Rosiglitazone—Diarrhoea—Furosemide—coronary artery disease	3.82e-05	0.00053	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.82e-05	0.00053	CcSEcCtD
Rosiglitazone—Pruritus—Losartan—coronary artery disease	3.81e-05	0.000529	CcSEcCtD
Rosiglitazone—Headache—Telmisartan—coronary artery disease	3.81e-05	0.000529	CcSEcCtD
Rosiglitazone—Dizziness—Perindopril—coronary artery disease	3.8e-05	0.000527	CcSEcCtD
Rosiglitazone—Nausea—Pravastatin—coronary artery disease	3.79e-05	0.000526	CcSEcCtD
Rosiglitazone—Rash—Captopril—coronary artery disease	3.73e-05	0.000518	CcSEcCtD
Rosiglitazone—Dermatitis—Captopril—coronary artery disease	3.73e-05	0.000517	CcSEcCtD
Rosiglitazone—Headache—Captopril—coronary artery disease	3.71e-05	0.000514	CcSEcCtD
Rosiglitazone—Dizziness—Furosemide—coronary artery disease	3.69e-05	0.000512	CcSEcCtD
Rosiglitazone—Diarrhoea—Losartan—coronary artery disease	3.69e-05	0.000511	CcSEcCtD
Rosiglitazone—Nausea—Trandolapril—coronary artery disease	3.68e-05	0.00051	CcSEcCtD
Rosiglitazone—Urticaria—Ramipril—coronary artery disease	3.67e-05	0.000509	CcSEcCtD
Rosiglitazone—Nausea—Enalapril—coronary artery disease	3.66e-05	0.000508	CcSEcCtD
Rosiglitazone—Rash—Perindopril—coronary artery disease	3.62e-05	0.000502	CcSEcCtD
Rosiglitazone—Dermatitis—Perindopril—coronary artery disease	3.62e-05	0.000502	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.62e-05	0.000502	CcSEcCtD
Rosiglitazone—Nausea—Telmisartan—coronary artery disease	3.61e-05	0.000501	CcSEcCtD
Rosiglitazone—Fatigue—Lisinopril—coronary artery disease	3.61e-05	0.000501	CcSEcCtD
Rosiglitazone—Headache—Perindopril—coronary artery disease	3.6e-05	0.000499	CcSEcCtD
Rosiglitazone—Urticaria—Timolol—coronary artery disease	3.59e-05	0.000498	CcSEcCtD
Rosiglitazone—Constipation—Lisinopril—coronary artery disease	3.58e-05	0.000497	CcSEcCtD
Rosiglitazone—Dizziness—Losartan—coronary artery disease	3.56e-05	0.000494	CcSEcCtD
Rosiglitazone—Rash—Furosemide—coronary artery disease	3.52e-05	0.000488	CcSEcCtD
Rosiglitazone—Dermatitis—Furosemide—coronary artery disease	3.52e-05	0.000488	CcSEcCtD
Rosiglitazone—Nausea—Captopril—coronary artery disease	3.51e-05	0.000488	CcSEcCtD
Rosiglitazone—Headache—Furosemide—coronary artery disease	3.5e-05	0.000485	CcSEcCtD
Rosiglitazone—Nausea—Perindopril—coronary artery disease	3.41e-05	0.000473	CcSEcCtD
Rosiglitazone—Rash—Losartan—coronary artery disease	3.4e-05	0.000471	CcSEcCtD
Rosiglitazone—Dermatitis—Losartan—coronary artery disease	3.39e-05	0.000471	CcSEcCtD
Rosiglitazone—Headache—Losartan—coronary artery disease	3.38e-05	0.000468	CcSEcCtD
Rosiglitazone—Urticaria—Lisinopril—coronary artery disease	3.33e-05	0.000462	CcSEcCtD
Rosiglitazone—Nausea—Furosemide—coronary artery disease	3.32e-05	0.00046	CcSEcCtD
Rosiglitazone—Asthenia—Ramipril—coronary artery disease	3.31e-05	0.00046	CcSEcCtD
Rosiglitazone—Pruritus—Ramipril—coronary artery disease	3.27e-05	0.000453	CcSEcCtD
Rosiglitazone—Asthenia—Timolol—coronary artery disease	3.24e-05	0.00045	CcSEcCtD
Rosiglitazone—Nausea—Losartan—coronary artery disease	3.2e-05	0.000444	CcSEcCtD
Rosiglitazone—Pruritus—Timolol—coronary artery disease	3.2e-05	0.000443	CcSEcCtD
Rosiglitazone—Diarrhoea—Ramipril—coronary artery disease	3.16e-05	0.000439	CcSEcCtD
Rosiglitazone—Diarrhoea—Timolol—coronary artery disease	3.09e-05	0.000429	CcSEcCtD
Rosiglitazone—Dizziness—Ramipril—coronary artery disease	3.06e-05	0.000424	CcSEcCtD
Rosiglitazone—Asthenia—Lisinopril—coronary artery disease	3.01e-05	0.000417	CcSEcCtD
Rosiglitazone—Dizziness—Timolol—coronary artery disease	2.99e-05	0.000414	CcSEcCtD
Rosiglitazone—Pruritus—Lisinopril—coronary artery disease	2.96e-05	0.000411	CcSEcCtD
Rosiglitazone—Rash—Ramipril—coronary artery disease	2.91e-05	0.000404	CcSEcCtD
Rosiglitazone—Dermatitis—Ramipril—coronary artery disease	2.91e-05	0.000404	CcSEcCtD
Rosiglitazone—Headache—Ramipril—coronary artery disease	2.89e-05	0.000402	CcSEcCtD
Rosiglitazone—Diarrhoea—Lisinopril—coronary artery disease	2.87e-05	0.000398	CcSEcCtD
Rosiglitazone—Rash—Timolol—coronary artery disease	2.85e-05	0.000395	CcSEcCtD
Rosiglitazone—Dermatitis—Timolol—coronary artery disease	2.85e-05	0.000395	CcSEcCtD
Rosiglitazone—Headache—Timolol—coronary artery disease	2.83e-05	0.000393	CcSEcCtD
Rosiglitazone—Dizziness—Lisinopril—coronary artery disease	2.77e-05	0.000384	CcSEcCtD
Rosiglitazone—Nausea—Ramipril—coronary artery disease	2.74e-05	0.000381	CcSEcCtD
Rosiglitazone—Nausea—Timolol—coronary artery disease	2.68e-05	0.000372	CcSEcCtD
Rosiglitazone—Rash—Lisinopril—coronary artery disease	2.64e-05	0.000367	CcSEcCtD
Rosiglitazone—Dermatitis—Lisinopril—coronary artery disease	2.64e-05	0.000366	CcSEcCtD
Rosiglitazone—Headache—Lisinopril—coronary artery disease	2.62e-05	0.000364	CcSEcCtD
Rosiglitazone—Nausea—Lisinopril—coronary artery disease	2.49e-05	0.000345	CcSEcCtD
Rosiglitazone—CYP2C19—Metabolism—PSMA6—coronary artery disease	1.71e-06	3.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PSMB5—coronary artery disease	1.71e-06	3.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—MTHFR—coronary artery disease	1.71e-06	3.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LDLR—coronary artery disease	1.71e-06	3.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.71e-06	3.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.71e-06	3.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PLCB1—coronary artery disease	1.7e-06	3.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTT1—coronary artery disease	1.7e-06	3.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC9A1—coronary artery disease	1.7e-06	3.47e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.7e-06	3.46e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PLCB1—coronary artery disease	1.7e-06	3.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTT1—coronary artery disease	1.69e-06	3.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC9A1—coronary artery disease	1.69e-06	3.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CETP—coronary artery disease	1.68e-06	3.43e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GCLC—coronary artery disease	1.68e-06	3.43e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOE—coronary artery disease	1.68e-06	3.43e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.68e-06	3.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.67e-06	3.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CTGF—coronary artery disease	1.67e-06	3.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GCLC—coronary artery disease	1.67e-06	3.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CETP—coronary artery disease	1.67e-06	3.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SDC1—coronary artery disease	1.66e-06	3.39e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOA1—coronary artery disease	1.66e-06	3.39e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.66e-06	3.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMGCR—coronary artery disease	1.65e-06	3.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GOT2—coronary artery disease	1.65e-06	3.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCA1—coronary artery disease	1.65e-06	3.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SDC1—coronary artery disease	1.65e-06	3.36e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARG—coronary artery disease	1.65e-06	3.36e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—coronary artery disease	1.65e-06	3.36e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCA1—coronary artery disease	1.64e-06	3.35e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—POMC—coronary artery disease	1.63e-06	3.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AGT—coronary artery disease	1.62e-06	3.31e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—VCAN—coronary artery disease	1.62e-06	3.3e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALDOA—coronary artery disease	1.61e-06	3.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GGT1—coronary artery disease	1.6e-06	3.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GOT1—coronary artery disease	1.6e-06	3.26e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.59e-06	3.25e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GGT1—coronary artery disease	1.59e-06	3.24e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GOT1—coronary artery disease	1.59e-06	3.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOE—coronary artery disease	1.59e-06	3.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOA1—coronary artery disease	1.57e-06	3.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PSMB5—coronary artery disease	1.57e-06	3.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PSMA6—coronary artery disease	1.57e-06	3.21e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—DCN—coronary artery disease	1.56e-06	3.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PSMA6—coronary artery disease	1.56e-06	3.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PSMB5—coronary artery disease	1.56e-06	3.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.56e-06	3.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CTGF—coronary artery disease	1.54e-06	3.13e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CTGF—coronary artery disease	1.52e-06	3.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GOT2—coronary artery disease	1.52e-06	3.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMGCR—coronary artery disease	1.52e-06	3.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PLCB1—coronary artery disease	1.52e-06	3.1e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALDH2—coronary artery disease	1.52e-06	3.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMGCR—coronary artery disease	1.51e-06	3.08e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GOT2—coronary artery disease	1.51e-06	3.08e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.49e-06	3.04e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—coronary artery disease	1.48e-06	3.02e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.48e-06	3.01e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HBA1—coronary artery disease	1.48e-06	3.01e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	1.48e-06	3.01e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LIPC—coronary artery disease	1.48e-06	3.01e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2C19—coronary artery disease	1.48e-06	3.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCA1—coronary artery disease	1.48e-06	3.01e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOC3—coronary artery disease	1.47e-06	2.99e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARG—coronary artery disease	1.47e-06	2.99e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LDLR—coronary artery disease	1.46e-06	2.98e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.46e-06	2.97e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—POMC—coronary artery disease	1.45e-06	2.95e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC9A1—coronary artery disease	1.44e-06	2.94e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTT1—coronary artery disease	1.44e-06	2.94e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—coronary artery disease	1.44e-06	2.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTP1—coronary artery disease	1.44e-06	2.93e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTP1—coronary artery disease	1.43e-06	2.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GOT1—coronary artery disease	1.43e-06	2.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GGT1—coronary artery disease	1.43e-06	2.91e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GCLC—coronary artery disease	1.43e-06	2.91e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CETP—coronary artery disease	1.43e-06	2.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	1.42e-06	2.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HMOX1—coronary artery disease	1.42e-06	2.89e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NOS3—coronary artery disease	1.42e-06	2.89e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARGC1A—coronary artery disease	1.42e-06	2.89e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SDC1—coronary artery disease	1.41e-06	2.87e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HMOX1—coronary artery disease	1.41e-06	2.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PLCB1—coronary artery disease	1.4e-06	2.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CAT—coronary artery disease	1.4e-06	2.85e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CAT—coronary artery disease	1.39e-06	2.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PLCB1—coronary artery disease	1.39e-06	2.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARG—coronary artery disease	1.39e-06	2.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—POMC—coronary artery disease	1.37e-06	2.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.36e-06	2.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOB—coronary artery disease	1.36e-06	2.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCA1—coronary artery disease	1.36e-06	2.77e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOB—coronary artery disease	1.35e-06	2.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCA1—coronary artery disease	1.34e-06	2.74e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PSMA6—coronary artery disease	1.33e-06	2.72e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PSMB5—coronary artery disease	1.33e-06	2.72e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.33e-06	2.71e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTM1—coronary artery disease	1.32e-06	2.69e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—coronary artery disease	1.32e-06	2.69e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—coronary artery disease	1.32e-06	2.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GGT1—coronary artery disease	1.31e-06	2.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GOT1—coronary artery disease	1.31e-06	2.68e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTM1—coronary artery disease	1.31e-06	2.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GGT1—coronary artery disease	1.3e-06	2.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GOT1—coronary artery disease	1.3e-06	2.66e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CTGF—coronary artery disease	1.3e-06	2.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—LPL—coronary artery disease	1.3e-06	2.64e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—coronary artery disease	1.3e-06	2.64e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MAPK1—coronary artery disease	1.3e-06	2.64e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMGCR—coronary artery disease	1.29e-06	2.63e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GOT2—coronary artery disease	1.29e-06	2.63e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—LPL—coronary artery disease	1.29e-06	2.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTP1—coronary artery disease	1.28e-06	2.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	1.27e-06	2.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMOX1—coronary artery disease	1.27e-06	2.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GPX1—coronary artery disease	1.27e-06	2.58e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NOS3—coronary artery disease	1.26e-06	2.57e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GPX1—coronary artery disease	1.26e-06	2.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CAT—coronary artery disease	1.25e-06	2.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—coronary artery disease	1.25e-06	2.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CD36—coronary artery disease	1.23e-06	2.51e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CD36—coronary artery disease	1.23e-06	2.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPP2CA—coronary artery disease	1.22e-06	2.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOB—coronary artery disease	1.21e-06	2.47e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPP2CA—coronary artery disease	1.21e-06	2.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NOS3—coronary artery disease	1.19e-06	2.43e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLCB1—coronary artery disease	1.19e-06	2.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.18e-06	2.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTM1—coronary artery disease	1.18e-06	2.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.17e-06	2.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.17e-06	2.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MTHFR—coronary artery disease	1.17e-06	2.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.16e-06	2.37e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.16e-06	2.37e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MTHFR—coronary artery disease	1.16e-06	2.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.16e-06	2.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—LPL—coronary artery disease	1.16e-06	2.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.15e-06	2.35e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—coronary artery disease	1.15e-06	2.35e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCA1—coronary artery disease	1.15e-06	2.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CAT—coronary artery disease	1.15e-06	2.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CAT—coronary artery disease	1.14e-06	2.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GPX1—coronary artery disease	1.13e-06	2.3e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—coronary artery disease	1.12e-06	2.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOB—coronary artery disease	1.11e-06	2.27e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GGT1—coronary artery disease	1.11e-06	2.27e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GOT1—coronary artery disease	1.11e-06	2.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AGT—coronary artery disease	1.11e-06	2.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOB—coronary artery disease	1.11e-06	2.25e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AGT—coronary artery disease	1.1e-06	2.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CD36—coronary artery disease	1.1e-06	2.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—coronary artery disease	1.09e-06	2.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOE—coronary artery disease	1.09e-06	2.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPP2CA—coronary artery disease	1.09e-06	2.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.08e-06	2.21e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOE—coronary artery disease	1.08e-06	2.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.08e-06	2.19e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOA1—coronary artery disease	1.07e-06	2.19e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOA1—coronary artery disease	1.07e-06	2.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—LPL—coronary artery disease	1.06e-06	2.17e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—coronary artery disease	1.06e-06	2.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LPL—coronary artery disease	1.06e-06	2.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MTHFR—coronary artery disease	1.04e-06	2.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GPX1—coronary artery disease	1.04e-06	2.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPX1—coronary artery disease	1.03e-06	2.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.03e-06	2.1e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.02e-06	2.09e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—coronary artery disease	1.01e-06	2.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CD36—coronary artery disease	1.01e-06	2.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CD36—coronary artery disease	1e-06	2.04e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTP1—coronary artery disease	1e-06	2.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPP2CA—coronary artery disease	9.99e-07	2.04e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	9.91e-07	2.02e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPP2CA—coronary artery disease	9.9e-07	2.02e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AGT—coronary artery disease	9.9e-07	2.02e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMOX1—coronary artery disease	9.86e-07	2.01e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CAT—coronary artery disease	9.73e-07	1.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOE—coronary artery disease	9.7e-07	1.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOA1—coronary artery disease	9.59e-07	1.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MTHFR—coronary artery disease	9.59e-07	1.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MTHFR—coronary artery disease	9.5e-07	1.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARG—coronary artery disease	9.47e-07	1.93e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOB—coronary artery disease	9.45e-07	1.93e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARG—coronary artery disease	9.41e-07	1.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—POMC—coronary artery disease	9.34e-07	1.9e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—POMC—coronary artery disease	9.28e-07	1.89e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTM1—coronary artery disease	9.19e-07	1.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	9.18e-07	1.87e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—coronary artery disease	9.18e-07	1.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AGT—coronary artery disease	9.11e-07	1.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AGT—coronary artery disease	9.03e-07	1.84e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LPL—coronary artery disease	9.02e-07	1.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOE—coronary artery disease	8.92e-07	1.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOE—coronary artery disease	8.85e-07	1.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOA1—coronary artery disease	8.82e-07	1.8e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPX1—coronary artery disease	8.8e-07	1.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOA1—coronary artery disease	8.75e-07	1.78e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CD36—coronary artery disease	8.57e-07	1.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—coronary artery disease	8.51e-07	1.74e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPP2CA—coronary artery disease	8.46e-07	1.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARG—coronary artery disease	8.45e-07	1.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.37e-07	1.71e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—POMC—coronary artery disease	8.33e-07	1.7e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—coronary artery disease	8.27e-07	1.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NOS3—coronary artery disease	8.14e-07	1.66e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTHFR—coronary artery disease	8.12e-07	1.66e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NOS3—coronary artery disease	8.1e-07	1.65e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—coronary artery disease	7.97e-07	1.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARG—coronary artery disease	7.77e-07	1.58e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AGT—coronary artery disease	7.72e-07	1.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARG—coronary artery disease	7.71e-07	1.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—POMC—coronary artery disease	7.67e-07	1.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—POMC—coronary artery disease	7.6e-07	1.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—coronary artery disease	7.6e-07	1.55e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOE—coronary artery disease	7.56e-07	1.54e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOA1—coronary artery disease	7.47e-07	1.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—coronary artery disease	7.45e-07	1.52e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—coronary artery disease	7.41e-07	1.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NOS3—coronary artery disease	7.27e-07	1.48e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.16e-07	1.46e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—coronary artery disease	7.09e-07	1.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—coronary artery disease	6.99e-07	1.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—coronary artery disease	6.93e-07	1.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—coronary artery disease	6.71e-07	1.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NOS3—coronary artery disease	6.69e-07	1.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—coronary artery disease	6.65e-07	1.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NOS3—coronary artery disease	6.63e-07	1.35e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARG—coronary artery disease	6.58e-07	1.34e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—coronary artery disease	6.51e-07	1.33e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—POMC—coronary artery disease	6.49e-07	1.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—coronary artery disease	6.11e-07	1.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—coronary artery disease	6.06e-07	1.24e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—coronary artery disease	5.92e-07	1.21e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—coronary artery disease	5.8e-07	1.18e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NOS3—coronary artery disease	5.66e-07	1.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—coronary artery disease	5.48e-07	1.12e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—coronary artery disease	5.18e-07	1.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—coronary artery disease	4.58e-07	9.34e-06	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—coronary artery disease	4.56e-07	9.29e-06	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—coronary artery disease	4.09e-07	8.34e-06	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—coronary artery disease	3.76e-07	7.67e-06	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—coronary artery disease	3.74e-07	7.63e-06	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—coronary artery disease	3.73e-07	7.6e-06	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—coronary artery disease	3.72e-07	7.59e-06	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—coronary artery disease	3.34e-07	6.81e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—coronary artery disease	3.19e-07	6.5e-06	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—coronary artery disease	3.07e-07	6.27e-06	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—coronary artery disease	3.05e-07	6.21e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—coronary artery disease	2.6e-07	5.31e-06	CbGpPWpGaD
